TIDMNCYT
RNS Number : 7198V
Novacyt S.A.
07 November 2017
FOR THE SECOND YEAR RUNNING NOVACYT WINS
TECHNOLOGY FAST 50 AWARD
Paris, France and Cambridge, UK - 7 November 2017 - Novacyt
(EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in
clinical diagnostics, today announces it has won, for the second
consecutive year, the Ile-de-France award of the Deloitte
Technology Fast 50 French programme, an initiative that rewards
fast growing companies.
The Technology Fast 50 is one of France's foremost technology
award programmes. It is a ranking of the country's 50 fastest
growing technology companies, based on revenue growth over the last
four years. The Ile-de-France award recognises Novacyt as the
fastest growing listed technology company in the region, including
Paris, during the past four years.
Novacyt's three core strategic pillars centre on organic,
acquisition and R&D led growth. Through a combination of these
pillars, Novacyt has achieved this award by delivering strong
revenue growth averaging 113% between 2013 and 2016. In 2016, the
Group generated revenues of EUR11.1 million on a consolidated
basis, representing annual growth of 25%, with a 55% gross profit
margin, which was an increase of seven percentage points on the
previous year.
In line with the Group's continued commitment to commercial
expansion, part of the UK business recently moved into a
state-of-the-art manufacturing facility in Camberley. This new,
larger facility will accommodate increased manufacturing of Lab21
products with additional future capacity for NOVAprep(R), the
Company's proprietary technology platform.
Graham Mullis, Group CEO of Novacyt, commented:
"We take great pleasure in winning the Fast 50 Ile-de-France
award for the second consecutive year. This award recognises our
record of delivering significant long term growth. I would like to
thank all our employees for their dedication and commitment in
driving our business forward culminating in this achievement."
"We remain committed to our three core strategic pillars which
are delivering strong growth and put us on a pathway to sustainable
profitability."
- End -
About Deloitte Technology Fast 50 France
Now in its seventeenth year, the Technology Fast 50 France is
part of an international programme run by Deloitte. Qualifying
entrants of the Fast 50 France will be put forward to the Deloitte
Technology Fast 500 EMEA (Europe, Middle East and Africa)
programme, along with entrants from other national programmes run
by Deloitte in the EMEA region.
The Deloitte Technology Fast 50 awards recognise and profile
French technology companies, public or private, including some of
the most dynamic players in all areas of technology, from Internet
specialists to biotech, digital media technology to life sciences,
computers to semiconductors and software to telecommunications.
About Deloitte
Deloitte refers to one or more of Deloitte Touche Tohmatsu
Limited, a UK private company limited by guarantee, and its network
of member firms, each of which is a legally separate and
independent entity. Please see www.deloitte.com/about for a
detailed description of the legal structure of Deloitte Touche
Tohmatsu Limited and its member firms. In France, Deloitte SAS is
the member firm of Deloitte Touche Tohmatsu Limited, and
professional services are provided by its subsidiaries and
affiliates.
Deloitte provides audit, tax, consulting, and financial advisory
services to public and private clients spanning multiple
industries. With a globally connected network of member firms in
more than 150 countries, Deloitte brings world-class capabilities
and high-quality service to clients, delivering the insights they
need to address their most complex business challenges. Deloitte's
approximately 244,000 professionals are committed to becoming the
standard of excellence.
In France, Deloitte calls on diversified expertise to meet the
challenges of its clients of all sizes from all industries - major
multinationals, local micro-companies and medium-sized enterprises.
With the expertise of its 10 300 professionals and partners,
Deloitte is a leading player in audit, risk advisory, consulting,
financial advisory, tax & legal and accounting, based on a
multidisciplinary offering and a set of action principles attuned
to the requirements of our environment.
About Novacyt Group
The Novacyt Group is a rapidly growing, international
diagnostics group with a growing portfolio of cancer and infectious
disease products and services. Through its proprietary technology
platform, NOVAPrep(R), and molecular platform, genesig(R), Novacyt
is able to provide an extensive range of oncology and infectious
disease diagnostic products across an extensive international
distributor network. The Group has diversified sales from
diagnostic reagents used in oncology, microbiology, haematology and
serology markets, and its global customers and partners include
major corporates.
For more information please refer to the website:
www.novacyt.com
Contacts
Novacyt SA
Graham Mullis, Chief Executive Officer
Anthony Dyer, Chief Financial Officer
+44 (0)1223 395472
Stifel Nicolaus Europe Limited (Nominated Advisor and Joint
Broker)
Jonathan Senior / Fred Walsh / Ben Maddison
+44 (0)20 7610 7600
International
Brett Pollard / Victoria Foster Mitchell
FTI Consulting
+44 (0)20 3727 1000
brett.pollard@fticonsulting.com /
victoria.fostermitchell@fticonsulting.com
France
Arnaud de Cheffontaines / Astrid Villette
FTI Consulting
+33 (0)147 03 69 47 / +33 (0)147 03 69 51
arnaud.decheffontaines@fticonsulting.com /
astrid.villette@fticonsulting.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCUGGPWGUPMPUQ
(END) Dow Jones Newswires
November 07, 2017 02:00 ET (07:00 GMT)
Novacyt (LSE:NCYT)
Historical Stock Chart
From Apr 2024 to May 2024
Novacyt (LSE:NCYT)
Historical Stock Chart
From May 2023 to May 2024